Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines
暂无分享,去创建一个
F. Zoulim | D. Durantel | M. Lesurtel | U. Protzer | J. Mabrut | M. Rivoire | A. Salvetti | M. Bonnin | C. Ducerf | N. Bendriss-Vermare | G. Passot | S. Vegna | M. Broxtermann | Knud Esser | J. Lucifora | S. Faure-Dupuy | L. Aillot | L. Dimier
[1] Silvia Guzmán-Beltrán,et al. High glucose induces O‐GlcNAc glycosylation of the vitamin D receptor (VDR) in THP1 cells and in human macrophages derived from monocytes , 2017, Cell biology international.
[2] Xue-mei Ma,et al. TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs , 2017, Cytokine.
[3] K. Moraes,et al. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis , 2017, Cell biology international.
[4] F. Grossi,et al. Understanding the checkpoint blockade in lung cancer immunotherapy. , 2017, Drug discovery today.
[5] P. Mantecca,et al. Airborne Nanoparticle Release and Toxicological Risk from Metal-Oxide-Coated Textiles: Toward a Multiscale Safe-by-Design Approach. , 2017, Environmental Science and Technology.
[6] Benhong Xu,et al. Quantitative proteomic profiling for clarification of the crucial roles of lysosomes in microbial infections , 2017, Molecular immunology.
[7] S. Friedman,et al. Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.
[8] Z. Hou,et al. A Programmed Cell Death‐1 Haplotype is Associated with Clearance of Hepatitis B Virus , 2017, Annals of clinical and laboratory science.
[9] T. Greten,et al. Tumor regulation of the tissue environment in the liver , 2017, Pharmacology & therapeutics.
[10] F. Tacke,et al. Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.
[11] J. Mann,et al. Epigenetics and Liver Fibrosis , 2017, Cellular and molecular gastroenterology and hepatology.
[12] K. Breckpot,et al. PD1 signal transduction pathways in T cells , 2017, Oncotarget.
[13] K. Breckpot,et al. PD1 signal transduction pathways in T cells , 2017, Oncotarget.
[14] Z. Temesgen,et al. Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infection. , 2017, Drugs of today.
[15] G. Yoo,et al. PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report , 2016, Journal of Immunotherapy for Cancer.
[16] A. Medvedev,et al. Molecular mechanisms of regulation of Toll‐like receptor signaling , 2016, Journal of leukocyte biology.
[17] T. Yamashita,et al. The future of immunotherapy for sarcoma , 2016, Expert opinion on biological therapy.
[18] E. Assenat,et al. NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase , 2016, Journal of Virology.
[19] F. Zoulim,et al. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus. , 2016, Journal of hepatology.
[20] F. Ginhoux,et al. Tissue-Resident Macrophage Ontogeny and Homeostasis. , 2016, Immunity.
[21] J. Korbel,et al. Immortalization capacity of HPV types is inversely related to chromosomal instability , 2016, OncoTarget.
[22] F. Bertucci,et al. The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers , 2016, Oncoimmunology.
[23] Jennifer L. Anderson,et al. Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines , 2016, Pediatric Research.
[24] M. Ait-goughoulte,et al. Early inhibition of hepatocyte innate responses by hepatitis B virus. , 2015, Journal of hepatology.
[25] M. Ait-goughoulte,et al. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells. , 2015, Journal of hepatology.
[26] Anh-Hoa Nguyen,et al. Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis C , 2015, Antiviral therapy.
[27] B. Smedsrød,et al. Liver Sinusoidal Endothelial Cells. , 2015, Comprehensive Physiology.
[28] C. Coffin,et al. The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection. , 2015, Journal of hepatology.
[29] F. Zoulim,et al. P0535 : Direct antiviral effects of various pattern recognition receptor (PRR) agonists in HBV-replicating hepatocytes , 2015 .
[30] F. Zoulim,et al. An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium. , 2014, Biochemical and biophysical research communications.
[31] S. Akira,et al. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. , 2014, Cold Spring Harbor perspectives in biology.
[32] C. Figdor,et al. Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network , 2013, Front. Immunol..
[33] Z. Shusen,et al. Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B , 2012, BMC Gastroenterology.
[34] Percy A. Knolle,et al. Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.
[35] M. Odenthal,et al. Toll‐like receptor 2–mediated innate immune response in human nonparenchymal liver cells toward adeno‐associated viral vectors , 2012, Hepatology.
[36] I. N. Crispe,et al. Liver antigen-presenting cells. , 2011, Journal of hepatology.
[37] T. Billiar,et al. Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production. , 2010, Journal of hepatology.
[38] S. Akira,et al. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.
[39] D. Bienzle,et al. Structure and function of programmed death (PD) molecules. , 2010, Veterinary immunology and immunopathology.
[40] E. Alexandre,et al. Isolation and culture of primary hepatocytes from resected human liver tissue. , 2010, Methods in molecular biology.
[41] I. N. Crispe,et al. The liver as a lymphoid organ. , 2009, Annual review of immunology.
[42] F. Zoulim,et al. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.
[43] Mustapha Si-Tahar,et al. Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells1 , 2007, The Journal of Immunology.
[44] T. Iftner,et al. TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 161 , 2007, The Journal of Immunology.
[45] M. Severa,et al. Tumor Necrosis Factor Alpha Enhances Influenza A Virus-Induced Expression of Antiviral Cytokines by Activating RIG-I Gene Expression , 2006, Journal of Virology.
[46] S. Friedman,et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis , 2004, Gut.
[47] Z. Kmieć,et al. Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.
[48] K. Takeda,et al. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses , 2000, Immunological reviews.
[49] J. Köhrle,et al. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells ‐ regulation by 1,25‐dihydroxyvitamin D3 and selenite , 1999, BioFactors.
[50] T. Yamane,et al. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. , 1984, Gan.
[51] Ivan Damjanov,et al. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.